![Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - ScienceDirect Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419477612-gr1.jpg)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - ScienceDirect
![Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | Breast Cancer Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12282-020-01058-3/MediaObjects/12282_2020_1058_Fig3_HTML.png)
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | Breast Cancer
![Diagnostics | Free Full-Text | The Evaluation of 17 Gastrointestinal Tumor Markers Reveals Prognosis Value for MUC6, CK17, and CD10 in Gallbladder- Cancer Patients Diagnostics | Free Full-Text | The Evaluation of 17 Gastrointestinal Tumor Markers Reveals Prognosis Value for MUC6, CK17, and CD10 in Gallbladder- Cancer Patients](https://pub.mdpi-res.com/diagnostics/diagnostics-11-00153/article_deploy/html/images/diagnostics-11-00153-ag.png?1611223659)
Diagnostics | Free Full-Text | The Evaluation of 17 Gastrointestinal Tumor Markers Reveals Prognosis Value for MUC6, CK17, and CD10 in Gallbladder- Cancer Patients
![Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines | British Journal of Cancer Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6605462/MediaObjects/41416_2010_Article_BF6605462_Fig1_HTML.jpg)
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines | British Journal of Cancer
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
![PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/54ce5e0004d854229da124b4ed00755e2e2df55b/6-Table1-1.png)
PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar
![Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects](https://www.frontiersin.org/files/Articles/642380/fmed-08-642380-HTML/image_m/fmed-08-642380-g001.jpg)
Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
![IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma](https://www.mdpi.com/ijms/ijms-22-10271/article_deploy/html/images/ijms-22-10271-g001.png)